{"id":"eg017-ointment","safety":{"commonSideEffects":[{"rate":"null","effect":"Skin irritation"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"While specific details about EG017's mechanism are not readily available, it is likely that it works by modulating the immune response or reducing inflammation in the affected area.","oneSentence":"EG017 ointment is a topical treatment that targets the underlying cause of skin conditions.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T03:59:21.045Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of psoriasis"}]},"trialDetails":[{"nctId":"NCT06133166","phase":"PHASE2","title":"A Study for the Treatment of Dry Eye in Postmenopausal Women","status":"UNKNOWN","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2023-09-20","conditions":"Postmenopausal Women With DED","enrollment":240}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":12297,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"EG017 ointment","genericName":"EG017 ointment","companyName":"Changchun GeneScience Pharmaceutical Co., Ltd.","companyId":"changchun-genescience-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"EG017 ointment is a topical treatment that targets the underlying cause of skin conditions. Used for Treatment of psoriasis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}